U.S. FDA has authorized the emergency use of Pfizer and BioNTech’s mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possible full regulatory approval in 2021.   Under Operation Warp Speed, the Department of Defense (DoD) in partnership with agencies within the...